covid
Buscar en
Revista Médica Internacional sobre el Síndrome de Down (English Edition)
Toda la web
Inicio Revista Médica Internacional sobre el Síndrome de Down (English Edition) Vitamin D receptor gene polymorphisms in persons with Down's syndrome
Información de la revista
Vol. 10. Núm. 1.
Páginas 2-7 (marzo 2006)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 10. Núm. 1.
Páginas 2-7 (marzo 2006)
Original
Acceso a texto completo
Vitamin D receptor gene polymorphisms in persons with Down's syndrome
Visitas
700
Sara Panizo-Garcia1, Eva Parisi-Capdevila1, José Manuel Valdivielso-Revilla1, Lluís Rosselló-Aubach
,2
, Elvira Fernández-Giraldez3
1 Laboratori de Genètica Humana del Departament de Ciències Mèdiques, Bàsiques de la Universitat de Lleida
2 Servei de Reumatologia de l’Hospital de Santa Maria de Lleida
3 Servei de Nefrologia de l’Hospital Arnau de Vilanova de Lleida
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Abstract
Background

Down syndrome (DS) is a genetic alteration caused by having three copies of chromosome 21. Variations in the presence of alleles in the vitamin D receptor (VDR) gene have been linked to a variety in the phenotype and also considered a risk factor in some populations. In the present paper, we analyze whether a variation of the BsmI polymorphism in the VDR gene is overexpressed in patients with DS and whether it is related to any phenotype of the patients.

Patients and methods

We studied the BsmI polymorphism of the vitamin D receptor in DNA from peripheral blood of 85 patients with DS and 122 controls. The detection of each phenotype is performed by amplification of the DNA sequences of intron 8 of the VDR gene by polymerase chain reaction (PCR). We analyzed the differences in distribution of the alleles in patients with DS and the correlation of the genotype to different anthropometric (age, height, body mass index) and biochemical parameters (calcium, vitamin D,{PTH hormone, bone mass).

Results

The analysis of the distribution of the BsmI polymorphism showed a higher frequency of the B allele in the DS patients with respect to controls. In the same group of patients, regression analysis showed no link with any biochemical parameter. However, the homozygous genotype bb is more frequently found in taller individuals (p=0.04) and the BB in older individuals (p=0.03).

Conclusions

The B allele of the BsmI polymorphism of the VDR gene is more frequent in people with DS. The genotypes bb and BB are more frequent in taller and longer-living DS patients respectively. This result points out the possibility that VDR genotype could influence these two phenotypic characteristics of DS patients.

Keywords:
Vitamin D receptor gene
BsmI polymorphism
Down syndrome
Vitamin D
El Texto completo está disponible en PDF
References
[1]
H. Rehder, B. Fritz.
Genetic causes of mental retardation.
Wien Med Wochenschr, 155 (2005), pp. 258-267
[2]
S.E. Antonarakis.
10 years of Genomics, chromosome 21, and Down syndrome.
Genomics, 51 (1998), pp. 1-16
[3]
L.E. Olson, J.T. Richtsmeier, J. Leszl, R.H. Reeves.
A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
Science, 306 (2004), pp. 687-690
[4]
L.l. Roselló, R. Torres, T. Boronat, R. Lobet, E. Puerto.
Osteoporosis prevelence in a Down syndrome population, mesauring different parameters.
DS-SD International Medical Review on Down Syndrome, 8 (2004), pp. 18-22
[5]
N.A. Morrison, R. Yeoman, P.J. Kelly, J.A. Eisman.
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin.
PNAS, 89 (1992), pp. 6665-6669
[6]
A. Thakkinstian, C. D’Este, J. Eisman, T. Nguyen, J. Attia.
Meta-Analysis of molecular association studies: Vitamin D receptor gene polymorphisms and BMD as a case study.
JBMD, 19 (2004), pp. 419-428
[7]
D. Matusiak, G. Murillo, R.E. Carroll, R.G. Mehta, R.V. Benya.
Expression of vitamin D receptor and 25.hydroxyvitamin D3-1 alpha-hydroxylase in normal and malignant human colon.
Cancer Epidemiology Biomarkers and Prevention, 14 (2005), pp. 2370-2376
[8]
S. Muray, E. Parisi, A. Cardús, L. Craver, M.P. Marco, E. Fernández.
Influencia del polimorfismo del gen receptor de la vitamina D y de la 25-hidroxivitamina D en la tensión arterial de individuos sanos.
Nefrología, 23 (2003), pp. 32-36
[9]
D.H. Xiong, F.H. Xu, P.Y. Liu, H. Shen, J.R. Long, L. Elze, R.R. Recker, H.W. Deng.
Vitamin D receptor gene polymorphisms are linked to and associated with adult height.
J Med Genet, 42 (2005), pp. 228-234
[10]
E. Grundberg, H. Brändström, E.L. Ribom, Ö. Ljunggren, H. Mallmin, A. Kindmark.
Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women.
Eur J Endocrinology, 150 (2004), pp. 323-328
[11]
Zigman WB, Jenkins EC, Tycko B, Schupf N, Silverman W. Mortality is associated with apolipoprotein E epsilon4 in nondemented adults with Down syndrome. Nuerosci Lett; 390: 93-7.
[12]
S.M. Day, D.J. Strauss, R.M. Shavelles, R.J. Reynolds.
Mortality and causes of death in persons with Down syndrome in California.
Dev Med Child Neurol, 47 (2005), pp. 171-176
[13]
D.A. Hill, G. Gridley, S. Cnattingius, L. Mellemkjaer, M. Linet, H.O. Adami, J.H. Olsen, O. Nyren, J.F. Fraumeni Jr.
Mortality and cancer incidence among individuals with Down syndrome.
Arch intern Med, 163 (2003), pp. 705-711
[14]
T. Vacik, M. Ort, S. Gregorová, P. Strnad, R. Blatny, N. Conte, A. Bradley, J. Bures, J. Forejt.
Segmental trisomy of chromosome 17: A mouse model of human aneuploidy syndromes.
PNAS, 102 (2005), pp. 4500-4505
[15]
N. Angelopoulou, C. Matziari, V. Tsimaras, A. Sakadamis, V. Souftas, K. Mandroukas.
Bone mineral density and muscle strength in young men with mental retardation (with and without Down syndrome).
Calcified Tissue International, 66 (2000), pp. 176-180
Copyright © 2006. Fundació Catalana Síndrome Down
Descargar PDF
Opciones de artículo